lnu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Application of synthetic biology in infectious and communicable diseases
Adamas University, India.
Linnaeus University, Faculty of Health and Life Sciences, Department of Chemistry and Biomedical Sciences. Adamas University, India. (LNUC BMC)ORCID iD: 0000-0002-9334-9919
Adamas University, India.
Parul University, Waghodia, India.
2026 (English)In: Synthetic Biology and its Consequences in Present Healthcare / [ed] Bhupendra G. Prajapati; Biswajit Basu; Anirudha Dutta; Ayan Chatterjee, Elsevier, 2026, p. 181-200Chapter in book (Other academic)
Abstract [en]

Infectious diseases have profoundly impacted human history, causing economic turmoil and societal collapse. The Ebola epidemic (2013-16) strained West Africa’s fragile healthcare systems, while the severe acute respiratory syndrome coronavirus outbreak (2002-3) disrupted trade and travel, particularly in Canada and Singapore. More recently the COVID-19 pandemic has disrupted global socioeconomic structures, driving biologists to seek innovative solutions. Since the discovery of penicillin in 1928 antibiotics have revolutionized bacterial infection treatment, significantly reducing mortality rates. However research into new antibiotics declined after the mid-1950s, despite the growing challenge of antibiotic-resistant bacteria. Later, the invention of synthetic biology in early 2000s helped to design and modifie biological parts to address biomedical challenges. This chapter reviews recent advances in living therapeutics and diagnostics, highlighting their impact on infectious diseases and associated challenges.

Place, publisher, year, edition, pages
Elsevier, 2026. p. 181-200
Keywords [en]
Bacteria, COVID-19, Diagnosis, Economic and social effects, Economics, Viruses, Communicable disease, Genetic modification tool, Genetic modifications, Healthcare systems, Infectious disease, Severe acute respiratory syndrome coronavirus, Singapore, Socio-economics, Synthetic biology, West Africa, Antibiotics
National Category
Infectious Medicine
Identifiers
URN: urn:nbn:se:lnu:diva-150652DOI: 10.1016/B978-0-443-33649-2.00007-1Scopus ID: 2-s2.0-105023943910ISBN: 9780443336492 (print)ISBN: 9780443336508 (print)OAI: oai:DiVA.org:lnu-150652DiVA, id: diva2:2114976
Available from: 2026-11-03 Created: 2026-11-03 Last updated: 2026-11-03Bibliographically approved

Open Access in DiVA

No full text in DiVA

Other links

Publisher's full textScopus

Authority records

Chatterjee, Shilpa

Search in DiVA

By author/editor
Chatterjee, Shilpa
By organisation
Department of Chemistry and Biomedical Sciences
Infectious Medicine

Search outside of DiVA

GoogleGoogle Scholar

doi
isbn
urn-nbn

Altmetric score

doi
isbn
urn-nbn
Total: 3 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf